CELLCEPT
Generic: MYCOPHENOLATE MOFETIL
GenentechManufacturer
ORALRoute
MYCOPHENOLATE MOFETILActive Substance
1995-05-03Original Approval
CELLCEPT is FDA application NDA050722, sponsored by ROCHE PALO. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
20,344 reports
2
DRUG INEFFECTIVE
11,621 reports
3
PRODUCT USE IN UNAPPROVED INDICATION
7,426 reports
4
DIARRHOEA
7,211 reports
5
PYREXIA
5,839 reports
6
PNEUMONIA
5,519 reports
7
CYTOMEGALOVIRUS INFECTION
5,007 reports
8
FATIGUE
4,809 reports
9
NAUSEA
4,737 reports
10
CONDITION AGGRAVATED
4,653 reports